The hidden problem of herb-drug interactions
MARK GREENER
Potentially harmful interactions between herbs and prescription medicines are common, yet healthcare professionals often do not ask about herbal remedies when prescribing and patients do not volunteer that they are taking them. This article discusses the types of herb-drug interaction that can occur and how they can be recognised and avoided.
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For instance, St John's wor t (Hypericum perforatum) increases levels of the neurotransmitter serotonin. So, combining St John's wort and other serotonergic agents -such as SSRIscan trigger the potentially fatal serotonin syndrome. 3 St John's wort can also interact with oral contraceptives leading to unplanned pregnancies and breakthrough bleeding. 3 Yet while some potentially significant interactions are clear, pharmacologists are a long way from fully understanding the risks.
Types of interaction
Pharmacologists recognise three broad types of drug interaction: pharmaceutical incompatibility, pharmacodynamic and pharmacokinetic interactions. Pharmaceutical incompatibility refers to the complexes that form when certain drugs are mixed. This interaction underlies therapeutic chelation, such as using desferrioxamine to treat iron poisoning. 4 Pharmacodynamic interactions arise when the concomitant agents have similar or opposite pharmacological effects. 5 For example, concomitant ethanol can potentiate the sedative effects of benzodiazepines or the histamine H 1 -receptor antagonists used to alleviate travel sickness. 4 In European and Asian traditions, motherwort (Leonurus cardiaca) is used for, among other ailments, 'cardiac debility', tachycardia, anxiety, insomnia, and amenorrhoea. Motherwort is a sedative. With concomitant benzodiazepines, motherwort can have a synergistic sedative effect that could result in a coma. 6 The increase in serotonin levels with St John's wort and antidepressants or triptans used for migraine offers another example of a pharmacodynamic interaction. 3 Pharmacokinetic interactions occur when one drug affects the absorption, distribution, metabolism or excretion of a concomitant medicine. 4 Many pharmacokinetic interactions arise because of changes in levels of, or competition for, members of a group of enzymes called cytochrome P450s (CYPs). This ubiquitous group of enzymes has several biological actions. For instance, some of the 57 or so cytochrome P450s expressed by humans are involved in synthesis of steroid hormones, prostaglandins and bile acids. 7 In addition, about 12 cytochrome isoenzymes metabolise 70-80 per cent of all drugs in clinical use. 7 St John's wort illustrates how herbs can interact with prescription drugs by influencing the cytochrome P450 system. St John's wort is best known as an herbal treatment for depression and anxiety. But patients may take St John's wort for a variety of other ailments including sleep disorders, the common cold, herpes, HIV infection, as a topical analgesic, and as an enema for ulcerative colitis. 6 However, St John's wort potentially reduces the concentration or effect of several drugs including warfarin, ciclosporin, HIV protease inhibitors, theophylline, digoxin and oral contraceptives. These interactions probably occur as a result of induction of the cytochrome P450 isoenzymes, such as CYP3A4, CYP2C9 and CYP1A2.
3 P-glycoprotein is responsible for other interactions between herbs and prescription medicines. This transmembrane transporter, which is vital for the elimination, absorption or both of many drugs, is extensively expressed by the intestinal epithelium, hepatocytes, renal proximal tubular cells, the adrenal gland and the blood-brain barrier.
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Finding the culprit
To complicate matters further, isolating the chemicals in the herb responsible for the benefits, risks and interactions is time consuming. St John's wort, for example, contains at least nine groups of compounds that may contribute to its pharmacological effect. 3 Levels may also vary according to where the plant grows and the time of year. Despite its legendary toxicity, yew is used in some medical traditions, such as in parts of northern India, Pakistan and Nepal. With the exception of the aril (the fleshy red seed cover), yew, whether fresh or dried, contains a group of cardiotoxins called taxines. Levels of taxines peak during the winter. 8, 9 Herbalists believe that various chemicals in a plant act together to increase effectiveness -so-called synergy. Some components, herbalists contend, work together to reduce the risk of sideeffects; an effect known as buffering. So herbalists often use several plants together. 10 For example, the traditional Chinese herbal remedies Jia Wei Xiao Yao San and Chai Hu Shu Gan Tang, which seem to prolong survival in people with liver cancer when used alongside conventional treatments, contain 10 and seven plants respectively.
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"Herbs contain numerous biologically active substances, but there is also batch-to-batch variation, which makes it difficult to understand mechanisms," Professor Pirmohamed tells Prescriber. "However, if there is clinical evidence of an interaction, or if it can be surmised from the known activities of the herbal compounds, it is still possible to understand the pharmacology." Individually, for example, garlic, feverfew and ginseng all modestly inhibit platelet aggregation. In combination, they may have had a significant effect on platelet function. In one case, the interaction between the herbs contributed to an admission for bleeding from an inflamed oesophagus. 2 Moreover, pharmacologists increasingly recognise the limitations of interaction studies, which have important implications for the use of conventional drugs. Most interactions studies involve two drugs, usually in healthy volunteers. But patients often receive several drugs and have a range of diseases, some of which may influence metabolic capacity. Inflammation, for example, reduces levels of CYP3A4/5, CYP2C9 and CYP1A2, but increases levels of CYP2E1. Many patients are elderly and levels of several cytochrome P450 enzymes, including CYP3A4/5, CYP2C9 and CYP1A2, increase with advancing age. 7 Meanwhile, polymorphisms in the genes encoding cytochrome P450 and other metabolic enzymes can dramatically influence the pharmacodynamics of several drugs. Numerous environmental factors also influence cytochrome P450 levels. For example, in mice at least, differences in the microbiome (see below) can alter expression of more than 100 genes in the liver, including those encoding cytochrome P450. Yet such factors are poorly understood and rarely considered in interaction studies.
"As our population ages, and patients survive with multiple co-morbidities and are on multiple drugs, then the likelihood of interactions is going to increase," Professor Pirmohamed says. "Although we test for interactions in early phase studies, these are often done in healthy volunteers, who may be poor proxies for elderly patients, who are at highest risk. Thus, an interaction that may not be evident in a young person may suddenly become quite serious in an elderly person with multiple diseases on multiple drugs. The challenge for us is to start thinking about how we can detect and predict these types of interactions: it would be impossible to undertake specific studies as every elderly patient is different." The microbiome: another layer of complexity Recent advances in pharmacologists' understanding of the mechanisms underlying drug interactions adds another layer of complexity to this common problem. The gut microbiome, for example, consists of some 100 trillion cells from thousands of different species including bacteria, fungi, protozoa and viruses. Indeed, there are 10 cells in the microbiome for every cell in the human body. The microbiome is essential for health and wellbeing. Bacteria in the gut break down otherwise indigestible plant fibre, 12 which could have implications for herbal interactions. Other members of the microbiome synthesise essential vitamins and amino acids, aid the development and maintenance of the immune system, and detoxify drugs and other foreign material. 12 In the late 1930s, for example, researchers reported that the sulfonamide antibiotic prontosil did not seem to be effective in vitro, but was a broad-spectrum antibacterial in vivo. Researchers resolved the paradox when they found that bacteria in the gut activated prontosil. Today, researchers have identified at least 50 drugs metabolised by the gut microbiota -according to in vitro or in vivo studies or both -although this is almost certainly an underestimate. 12 Variations in the microbiome can contribute to the efficiency and tolerability of drugs. For instance, gut bacteria activate sulfasalazine, used for ulcerative colitis and rheumatoid arthritis. Gut bacteria also inactivate 5-aminosalicylic acid, sulfasalazine's active metabolite. Levels of the bacterial enzymes responsible for the inactivation can vary up to 10-fold between individuals.
12 "Metabolism by the gut microbiome is likely to be important for many prescription drugs as well as herbs," Professor Pirmohamed says. "However, this is a vast area that, even for prescription drugs, is not yet well studied."
Ask patients about herbal remedies
While there is unequivocal evidence of potentially harmful interactions between some herbs and certain prescription medicines, many probably go unrecognised, Professor Pirmohamed notes. In the Liverpool audit, for example, 46 per cent of the people using herbal treatments were using a preparation with known side-effects or documented interactions.
